+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Early Bird

Life Science Technical Accounting Update 2025 (ONLINE EVENT: May 14-15, 2025)

2 Days: May 14th 08:45 - May 15th 16:55 EST
  • Conference
  • Accounting Conferences and Seminars LLC
  • ID: 6024719
OFF until Apr 11th 2025

From Gross to Net Estimates and Accruals to Preparing for an IPO to Government Pricing for Biotechs to Revenue Recognition examples and latest updates, this conference will address the latest developments in key areas. You’ll hear from experts at Deloitte, Ernst & Young, Effectus Group, life science analysts and your industry counterparts.  

LEARNING OBJECTIVES:

  • Understand the latest accounting changes in key areas
  • Recognize the timelines and key factors affecting the life science industry
  • Begin to assess the effects of these standards on your company or clients

Certifications:

  • Earn up to 16 CPE Credits

Agenda

Agenda: DAY 1

8:45 - 10:10 - Recent Accounting Trends in the Life Science Industry

  • Collaboration Accounting
  • Grants
  • Inbound Licenses
  • Accounting for Financing Arrangements

10:10 - 10:20 - Break

10:20 - 11:30 - Tax Update

  • Latest legislative developments
  • Key Tax Proposals
  • Build Back Better Act Observations
  • Possible timing and other legislative priorities

11:30 - 12:15 - Lunch Break

12:15 - 1:35 - Revenue Recognition: Evolving Issues - Life Sciences

  • Scope of Contract
  • Performance Obligations
  • Nature of promise: sales of points
  • Collaboration agreements
  • Sales using third party platforms
  • Gross vs Net
  • Counterparty Perspective

1:35 - 1:50 - Break

1:50 - 3:15 - Regulatory Update

  • Cybersecurity Risk Management, Strategy Governance and Incident Disclosure
  • Market Trends
  • SEC Requirements Explained
  • The Framework
  • Disclosure Examples
  • Financial Accounting Update
  • FASB Project Update
  • ASUs
  • Issues on the horizon

3:15 - 3:25 - Break

3:25 - 4:45 - SOX & Internal Controls Update

  • Risk Assesment
  • Management Review Controls
  • Information Used in Controls
  • IT - General Controls Considerations

Agenda: DAY 2

8:45 - 10:00 - GenAI Use Cases in Accounting & Finance

  • Examine risks and myths
  • Explore AI use cases
  • Define steps for adopting AI
  • Practical use cases for today
  • Exciting use cases for tomorrow

10:00 - 10:15 - Break

10:15 - 11:45 - Gross to Net

  • Introduction and Overview
  • Industry View
  • Estimation Methodology
  • Approaching Launch
  • Key Challenges
  • SEC Comments
  • Close and Financial Reporting
  • GTN Hot Topics Discussion
  • Inventory Accounting Refresh

11:45 - 12:20 - Lunch Break

12:20 - 1:40 - Financing Trends

  • Royalty Monetization
  • Convertible Debt
  • Accounting Considerations
  • When should companies consider convertible debt?
  • Convertible structure in the life science financing cycle
  • Changes of control, tax implications, size, maturity and other questions

1:40 - 1:50 - Break

1:50 - 3:10 - Accounting for R&D and Clinical Trials

  • R&D Funding Arrangements
  • R&D Cost Classifications
  • Other Intangible Assets
  • SEC Comment Letter Trends

3:10 - 3:20 - Break

3:20 - 4:40 - ESG

  • ESG Landscape: Regulatory Developments
  • Operationalizing ESG & Sustainability
  • Disclosure Trends in the Life Sciences Industry
  • Taking Action

Speakers

  • Nathan Mitchell Deloitte, Partner
  • Alex Miller Deloitte, Senior Manager
  • Marcus Lindner Ernst & Young, Partner
  • Shikha Jain Deloitte, Managing Director
  • Jason Pikoos Connor Group, Managing Partner and AI Leader
  • Christie Hutchinson Effectus Group, Director
  • Luke Wilson KPMG, Manager
  • Richard Ho KPMG, Director
  • Christine Moore PwC, Director, National Quality Organization
  • Melissa Streig PwC, Director
  • Aleks Zabreyko Connor Group, Managing Partner
  • Jeffrey Kummer Deloitte, Director of Tax Policy
  • Joshua Areola Ernst & Young, Assurance Senior Manager
  • Sunny Patadia Ernst & Young, Assurance Senior Manager
  • James Bowie Ernst & Young, Managing Director, Technical Accounting Advisory Group
  • Kim Tran Ernst & Young, Assurace Senior Manager
  • Tanner Schnitz Ernst & Young, Technical Accounting Manager
  • Cavan Boylan Ernst & Young, Manager, Technical Accounting Advisory Group
  • Randa Ghantous Connor Group, Partner
  • Matt Lepley Connor Group, Partner
  • Boyan Zhao Effectus Group, Director - Technical Accounting & IPO Services
  • Christie Hutchinson Effectus Group, Managing Director, Technical Accounting & IPO

Who Should Attend

  • CFOs (and their staff)
  • Controllers
  • VPs of Finance
  • Financial Managers
  • Internal Auditors
  • Tax Accountants
  • Treasury Staff
  • Accountants in Industry
  • Internal Control/SOX personnel
  • Consultants
  • Public Accountants
  • Educators